华润医药：刘长安获委任为执行董事

Core Viewpoint - China Resources Pharmaceutical (03320) announced changes in its executive board, with Deng Rong resigning as an executive director and executive committee member, and Liu Chang'an appointed as the new executive director and executive committee member starting from September 18, 2025 [1] Company Summary - Deng Rong will resign from her position as executive director and member of the executive committee effective September 18, 2025 [1] - Liu Chang'an has been appointed as the new executive director and member of the executive committee, effective from the same date [1]